AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteAP26113 has exhibited activity as a potent dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR).
More Information Supplier PageAP26113 has exhibited activity as a potent dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR).
More Information Supplier PageAP26113 has exhibited activity as a potent dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR).
More Information Supplier PageAP26113 has exhibited activity as a potent dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR).
More Information Supplier PageAP26113 has exhibited activity as a potent dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR).
More Information Supplier PageApatinib (YN968D1) is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2, also known as KDR) that inhibits VEGF-mediated endothelial cell migration and proliferation thus blocking new blood vessel formation in tumor tissue.
More Information Supplier PageApatinib (YN968D1) is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2, also known as KDR) that inhibits VEGF-mediated endothelial cell migration and proliferation thus blocking new blood vessel formation in tumor tissue.
More Information Supplier PageApatinib (YN968D1) is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2, also known as KDR) that inhibits VEGF-mediated endothelial cell migration and proliferation thus blocking new blood vessel formation in tumor tissue.
More Information Supplier PageApatinib (YN968D1) is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2, also known as KDR) that inhibits VEGF-mediated endothelial cell migration and proliferation thus blocking new blood vessel formation in tumor tissue.
More Information Supplier PageApatinib (YN968D1) is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2, also known as KDR) that inhibits VEGF-mediated endothelial cell migration and proliferation thus blocking new blood vessel formation in tumor tissue.
More Information Supplier PageApaziquone is an indolequinone bioreductive prodrug and analog of mitomycin C with potential antineoplastic and radiosensitization activities.
More Information Supplier PageApaziquone is an indolequinone bioreductive prodrug and analog of mitomycin C with potential antineoplastic and radiosensitization activities.
More Information Supplier PageApaziquone is an indolequinone bioreductive prodrug and analog of mitomycin C with potential antineoplastic and radiosensitization activities.
More Information Supplier PageApaziquone is an indolequinone bioreductive prodrug and analog of mitomycin C with potential antineoplastic and radiosensitization activities.
More Information Supplier PageAPD668 is a potent GPR119 agonist with EC50 of 2.7 nM and 33 nM for hGPR119 and ratGPR119 respectively.
More Information Supplier PageAPD668 is a potent GPR119 agonist with EC50 of 2.7 nM and 33 nM for hGPR119 and ratGPR119 respectively.
More Information Supplier PageAPD668 is a potent GPR119 agonist with EC50 of 2.7 nM and 33 nM for hGPR119 and ratGPR119 respectively.
More Information Supplier PageApicidin is a a potent histone deacetylases (HDAC) inhibitor with potential anticancer activity.
More Information Supplier PageApicidin is a a potent histone deacetylases (HDAC) inhibitor with potential anticancer activity.
More Information Supplier PageApicidin is a a potent histone deacetylases (HDAC) inhibitor with potential anticancer activity.
More Information Supplier PageApicidin is a a potent histone deacetylases (HDAC) inhibitor with potential anticancer activity.
More Information Supplier PageApigenin, found in many plants, is a natural product belonging to the flavone class that is the aglycone of several naturally-occurring glycosides. Apigenin acts as a monoamine transporter activator, one of the few chemicals demonstrated to possess this property. Apigenin is a ligand for central benzodiazepine receptors that competitively inhibited the binding of flunitrazepam with […]
More Information Supplier PageApigenin, found in many plants, is a natural product belonging to the flavone class that is the aglycone of several naturally-occurring glycosides. Apigenin acts as a monoamine transporter activator, one of the few chemicals demonstrated to possess this property. Apigenin is a ligand for central benzodiazepine receptors that competitively inhibited the binding of flunitrazepam with […]
More Information Supplier PageApigenin, found in many plants, is a natural product belonging to the flavone class that is the aglycone of several naturally-occurring glycosides. Apigenin acts as a monoamine transporter activator, one of the few chemicals demonstrated to possess this property. Apigenin is a ligand for central benzodiazepine receptors that competitively inhibited the binding of flunitrazepam with […]
More Information Supplier PageApigenin, found in many plants, is a natural product belonging to the flavone class that is the aglycone of several naturally-occurring glycosides. Apigenin acts as a monoamine transporter activator, one of the few chemicals demonstrated to possess this property. Apigenin is a ligand for central benzodiazepine receptors that competitively inhibited the binding of flunitrazepam with […]
More Information Supplier PageApigenin-7-O-beta-D-glucopyranoside, extracted from Andrographis paniculata Nees. dried parts on the ground.
More Information Supplier PageApigenin-7-O-beta-D-glucopyranoside, extracted from Andrographis paniculata Nees. dried parts on the ground.
More Information Supplier PageApigenin-7-O-beta-D-glucopyranoside, extracted from Andrographis paniculata Nees. dried parts on the ground.
More Information Supplier PageApiin, a major flavonoid component of celery, shows antiinflammatory activity mediated through inhibition of nitric oxide synthesis and inhibition of iNOS expression.
More Information Supplier PageApiin, a major flavonoid component of celery, shows antiinflammatory activity mediated through inhibition of nitric oxide synthesis and inhibition of iNOS expression.
More Information Supplier PageApiin, a major flavonoid component of celery, shows antiinflammatory activity mediated through inhibition of nitric oxide synthesis and inhibition of iNOS expression.
More Information Supplier PageApilimod is a potent IL-12/IL-23 inhibitor, IL-12 production in cultures of IFN-r/LPS?Cstimulated human PBMCs is strongly inhibited by STA-5326 with an IC50 of 10 nM.
More Information Supplier PageApilimod is a potent IL-12/IL-23 inhibitor, IL-12 production in cultures of IFN-r/LPS?Cstimulated human PBMCs is strongly inhibited by STA-5326 with an IC50 of 10 nM.
More Information Supplier PageApilimod is a potent IL-12/IL-23 inhibitor, IL-12 production in cultures of IFN-r/LPS?Cstimulated human PBMCs is strongly inhibited by STA-5326 with an IC50 of 10 nM.
More Information Supplier PageApixaban is an anticoagulant for the prevention of venous thromboembolism and venous thromboembolic events.
More Information Supplier PageApixaban is an anticoagulant for the prevention of venous thromboembolism and venous thromboembolic events.
More Information Supplier PageApixaban is an anticoagulant for the prevention of venous thromboembolism and venous thromboembolic events.
More Information Supplier PageApixaban is an anticoagulant for the prevention of venous thromboembolism and venous thromboembolic events.
More Information Supplier PageApixaban is an anticoagulant for the prevention of venous thromboembolism and venous thromboembolic events.
More Information Supplier PageAplaviroc is a CCR5 entry inhibitor developed for the treatment of HIV infection.
More Information Supplier PageAplaviroc is a CCR5 entry inhibitor developed for the treatment of HIV infection.
More Information Supplier PageAplaviroc is a CCR5 entry inhibitor developed for the treatment of HIV infection.
More Information Supplier PageApoptosis Activator 2 activates caspases in a cytochrome c-dependent manner and induces apoptosis in tumor cells by promoting the oligomerization of Apaf-1 into the mature apoptosome.
More Information Supplier Page
